BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 14, 2025; 31(38): 109802
Published online Oct 14, 2025. doi: 10.3748/wjg.v31.i38.109802
Multimodal artificial intelligence technology in the precision diagnosis and treatment of gastroenterology and hepatology: Innovative applications and challenges
Yi-Mao Wu, Fei-Yang Tang, Zi-Xin Qi
Yi-Mao Wu, Fei-Yang Tang, The Second Clinical Medical College, Guangdong Medical University, Dongguan 523808, Guangdong Province, China
Zi-Xin Qi, College of Pharmacy, Guangdong Medical University, Dongguan 523808, Guangdong Province, China
Co-first authors: Yi-Mao Wu and Fei-Yang Tang.
Author contributions: Wu YM, Tang FY and Qi ZX contributed to searching, analyzing, writing-original draft preparation; Wu YM and Tang FY contributed to writing, reviewing; Wu YM and Qi ZX contributed to reviewing, editing; Wu YM contributed to reviewing, editing and supervision; All authors approved the final version of the manuscript.
Conflict-of-interest statement: The authors report no relevant conflicts of interest for this article.
Corresponding author: Yi-Mao Wu, Academic Fellow, The Second Clinical Medical College, Guangdong Medical University, No. 1 Xincheng Avenue, Songshan Lake District, Dongguan 523808, Guangdong Province, China. wuyimao_doctor@gdmu.edu.cn
Received: May 22, 2025
Revised: June 22, 2025
Accepted: August 26, 2025
Published online: October 14, 2025
Processing time: 145 Days and 18.5 Hours
Core Tip

Core Tip: This manuscript systematically reviews the latest progress in multimodal artificial intelligence (AI) in gastroenterology and hepatology, focusing on innovative applications, including endoscopic AI (89% sensitivity for early gastric cancer detection), multi-omics models (42% objective response rate for programmed cell death 1-sensitive gastric cancer subtypes), magnetic resonance imaging-based liver fibrosis staging [area under the curve (AUC) = 0.89], and AI-driven hepatocellular carcinoma recurrence prediction (AUC = 0.91). It analyzes critical challenges (data standardization gaps, model “black boxes”) and proposes solutions (federated learning, interpretable frameworks), providing vital guidance for AI’s clinical translation to advance precision medicine.

Write to the Help Desk